| Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773) |
|---|
| 08/22/2006 | US7094780 3-aminoquinazolin-2,4-dione antibacterial agents |
| 08/22/2006 | US7094778 Nervous system disorders; muscular disorders; urogenital disorders; gastrointestinal disorders; repiratory system disorders; antiallergens; side effect reduction |
| 08/22/2006 | US7094777 5-HT2A receptor ligands |
| 08/22/2006 | CA2242102C Quinazoline derivatives as antitumor agents |
| 08/17/2006 | WO2006086787A1 Process of preparing ziprasidone mesylate |
| 08/17/2006 | WO2006085978A2 Conjugates of a cephalosporin derivative and a fluorophor precursor and related compounds as substrates for beta-lactamase gene expression |
| 08/17/2006 | WO2006085815A1 Thiazole derivatives, their process for their preparation and their use in therapy |
| 08/17/2006 | WO2006084934A1 Use of thiadiazolidine-derived compounds as neurogenic agents |
| 08/17/2006 | WO2006067311A3 Cdc25 phosphatase inhibitors |
| 08/17/2006 | WO2006055734A3 3-phenyl-pyrazole derivatives as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto |
| 08/17/2006 | WO2006031782A3 Salvinorin derivatives as opioid receptor ligands |
| 08/17/2006 | WO2006021213A3 Vasopressin v1a antagonists |
| 08/17/2006 | WO2005086895A3 Ion channel modulators |
| 08/17/2006 | WO2005037845A8 Benzothiazole and thiazole[5,5-b] pyridine compositions and their use as ubiquitin ligase inhibitors |
| 08/17/2006 | US20060183918 Beta 2-adrenergic receptor agonists |
| 08/17/2006 | US20060183913 N-[4-Methyl-5-(2-nitrooxy-ethyl)-thiazol-2-yl]-formamide for example; compound forms a naturally occurring metabolite when NO is released to slow or prevent drug tolerance; treating cardiovascular diseases, inflammation, psychiatric and neurological diseases, respiratory diseases, urogenital disorders |
| 08/17/2006 | US20060183897 Biaryl substituted triazoles as sodium channel blockers |
| 08/17/2006 | US20060183805 Non-oxidatively metabolized compounds and compositions, synthetic pathways therefor, and uses thereof |
| 08/17/2006 | US20060183785 For the treatment of pain; epilepsy, manic depression, bipolar disorder, depression, anxiety and diabetic neuropathy; 5-Methyl-1-[2'-(trifluoromethoxy)-1,1'-biphenyl-3-yl]-1H-pyrazole-3-carboxamide |
| 08/17/2006 | US20060183783 2-[3-(2-cyclopentanecarbonyl-4-methyl-phenyl)-ureido]-thiazol-4-yl} acetic acid; 2-[3-(4-Methyl-2-[2-methylpropoxy] phenyl)-ureido]-thiazol-4-yl}-acetic acid; activators of glucokinase; treatment of metabolic disorders, hyperglycemic agent, syndrome x, anticholesterol, hypertension etc. |
| 08/17/2006 | US20060183781 Novel thiazolylmethyl pyrazoles, method for the production thereof, and use thereof in dyes for keratin fibers |
| 08/17/2006 | US20060183780 Lipoxygenase (e.g. 15-lipoxygenase) inhbitors; less toxic; longer acting; more potent; fewer side effects; easily absorbed; higher oral bioavailability and/or lower clearance; 4-Methyl-1-(pyridine-2-sulfonyl)pyrazole-3-carboxylic acid (2-chloro-4-fluorophenyl)amide |
| 08/17/2006 | US20060183772 To inhibit tumor growth in an animal; to induce apoptosis |
| 08/17/2006 | US20060183762 3-aminoquinazolin-2,4-dione antibacterial agents |
| 08/17/2006 | US20060183739 Carbonyl compounds |
| 08/17/2006 | US20060183731 7 and 8 membered heterocyclic cyclopentyl benzylamide modulators of chemokine receptor activity |
| 08/17/2006 | US20060183718 Thiazole-based nitric oxide donors having aryl substituent(s) and uses thereof |
| 08/17/2006 | CA2593497A1 Amorphous ziprasidone mesylate |
| 08/17/2006 | CA2591670A1 Process of preparing ziprasidone mesylate |
| 08/16/2006 | EP1690538A1 Isoxazole derivative having agonistic activity against peroxisome proliferator-activated receptor |
| 08/16/2006 | EP1689745A1 Novel macrocycles for treating tumor diseases |
| 08/16/2006 | EP1689743A2 Piperidinyl-and piperazinyl-sulfonylmethyl hydroxamic acids and their use as protease inhibitors |
| 08/16/2006 | EP1689729A1 Tetronic and tetramic acids as inhibitors of beta-secrease |
| 08/16/2006 | EP1689726A1 5-(benz- (z) -ylidene) -thiazolidin-4-one derivatives as immunosuppressant agents |
| 08/16/2006 | EP1689718A1 1-amino-isoquinoline derivatives for the treatment of diseases associated with inappropriate alk5 activity |
| 08/16/2006 | EP1689406A2 Heterocyclic inhibitors of mek and methods of use thereof |
| 08/16/2006 | EP1689394A1 Amino substituted pyridinyl methanone compounds useful in treating kinase disorders |
| 08/16/2006 | EP1689392A1 N-heteroaryl indole carboxamides and analogues thereof, for use as glucokinase activators in the treatment of diabetes |
| 08/16/2006 | EP1689391A2 5-phenyl-4-methyl-thiazol-2-yl-amine derivatives as inhibitors of phosphatidylinositol 3 kinase enzymes (pi3) for the treatment of inflammatory airway diseases |
| 08/16/2006 | EP1689387A2 Bicyclic inhibitors of mek and methods of use thereof |
| 08/16/2006 | EP1689233A2 Bicyclic inhibitors of mek and methods of use thereof |
| 08/16/2006 | EP1689231A2 Insecticidal n-(heteroarylalkyl) alkanediamine derivatives |
| 08/16/2006 | EP1583752B1 Cyclization process for substituted benzothiazole derivatives |
| 08/16/2006 | EP1513835B1 Piperazinylacylpiperidine derivatives, their preparation and therapeutic use thereof |
| 08/16/2006 | EP1487437B1 Use of selective ep4 receptor agonists for the treatment of diseases |
| 08/16/2006 | EP1397488B1 Novel compounds for chemiluminescense procedures |
| 08/16/2006 | EP1368320B1 Substituted 2-oxy-3,5-dicyano-4-aryl-6-aminopyridines and use thereof |
| 08/16/2006 | EP1191019B1 Intermediates for the synthesis of benzimidazole compounds and process for the preparation thereof |
| 08/16/2006 | EP1087941B1 Thiolesters and uses thereof |
| 08/16/2006 | EP1019075B9 Beta 2-adrenergic receptor agonists |
| 08/16/2006 | EP0861236B2 Cyclic and heterocyclic n-substituted alpha-iminohydroxamic and carboxylic acids |
| 08/16/2006 | CN1820007A Aryl-substituted benzo[d]isothiazol-3-ylamine analogues as capsaicin receptor modulators |
| 08/16/2006 | CN1817880A 2-bit-substituted quinolone compound and use in pharmacey |
| 08/16/2006 | CN1269821C Polymorphs of an epothilone analog |
| 08/16/2006 | CN1269813C Imidazolo-5-yl-2-anilino-pyrimidines as agents for inhibition of cell proliferation |
| 08/16/2006 | CN1269811C Piperazine derivatives having SST1 antagonistic activity |
| 08/16/2006 | CN1269804C Metalloproteinase inhibitors |
| 08/16/2006 | CN1269801C Amino acid derivatives and drug containing the same as the active ingredient |
| 08/15/2006 | US7091359 Process for the preparation of thiazolidinedione derivatives |
| 08/15/2006 | US7091343 Compositions useful as inhibitors of protein kinases |
| 08/15/2006 | US7091247 urotensin antagonists; vasoactive agents |
| 08/15/2006 | US7091230 2-aryloxy-2-arylalkanoic acids for diabetes and lipid disorders |
| 08/15/2006 | US7091228 4-[4'-(1,3-Benzothiazol-2-ylamino)-1,1'-biphenyl-4-yl]-2,2-dimethyl-4-oxobutanoic acid and derivatives; inhibition of DGAT-1 (diacylglycerol O-acyltransferase type 1) |
| 08/15/2006 | US7091227 Serine/threonine and tyrosine kinases inhibitors |
| 08/15/2006 | US7091223 Autoimmune diseases; anticancer agents |
| 08/15/2006 | US7091219 Administering an effective amount of bis-sulfonamide hydroxyethyl-amino derivative to a HIV patient to prevent the viral replication |
| 08/15/2006 | US7091217 Chemokine receptor binding heterocyclic compounds |
| 08/15/2006 | US7091209 Dihydroxypyridmidine carboxylic acids as viral polymerase inhibitors |
| 08/15/2006 | US7091200 adrenoceptor or G-protein coupled receptors inhibitors such as 3-(6,7-dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)-6,7-dimethoxy-2H-benzo[1,2,4]-thiadiazine-1,1-dioxide and carriers, used for prophylaxis of urogenital disorders, or as analgesics |
| 08/15/2006 | US7091196 triazoles and optionally carrier mixtures used for prohylaxis of infections, as antiproliferative agents, fungicides, bactericides, parasiticides, viricides, antiinflammatory agents and/or prokinetic agents (gastrointestinal modulatory) |
| 08/15/2006 | US7091184 Hepatitis C inhibitor tri-peptides |
| 08/15/2006 | CA2200126C Treatment and prophylaxis of pancreatitis |
| 08/15/2006 | CA2168193C Aryalkyl-thiadiazinones |
| 08/10/2006 | WO2006084017A2 Phenyl-substituted pyrimidine compounds useful as kinase inhibitors |
| 08/10/2006 | WO2006083781A1 Antidiabetic bicyclic compounds |
| 08/10/2006 | WO2006083760A1 AMINO-PYRIDINES AS INHIBITORS OF β-SECRETASE |
| 08/10/2006 | WO2006083271A2 Substituted aryl acylthioureas and related compounds; inhibitors of viral replication |
| 08/10/2006 | WO2006082952A1 Amide compound |
| 08/10/2006 | WO2006082404A1 Compounds having tie2 (tek) inhibitory activity |
| 08/10/2006 | WO2006082373A1 Pyrimidine compounds having ties (tek) inhibitory activity |
| 08/10/2006 | WO2006082354A1 Azacyclic compounds as inhibitors of sensory neurone specific channels ( sns ) |
| 08/10/2006 | WO2006082107A1 Thiazolidinones for use as inhibitors of polo-like kinase (plk) |
| 08/10/2006 | WO2006082001A1 Heterocyclic substituted phenyl methanones as inhibitors of the glycine transporter 1 |
| 08/10/2006 | WO2006066778A3 Novel heteroarylacetamides |
| 08/10/2006 | WO2006053778A3 Amide derivatives, their manufacture and use as pharmaceutical agents |
| 08/10/2006 | WO2006040318A3 Pi3 kinase gamma inhibitors for the treatment of anaemia |
| 08/10/2006 | WO2005110406A3 Phenyl derivatives for the treatment of abnormal cell growth |
| 08/10/2006 | US20060178513 Pyridinylanilides |
| 08/10/2006 | US20060178429 2-Phenyl-3-hydrogenated furanyl, pyranyl, thiophenyl or thiopyranyl-N-heteroaromatic propionamides, e.g., 2-(3,4-Dichloro-phenyl)-3-(tetrahydro-pyran-2-yl)-N-thiazol-2-yl-propionamide; compounds increase insulin secretion in the treatment of type II diabetes. |
| 08/10/2006 | US20060178416 Quinoline derivatives as phosphodiesterase inhibitors |
| 08/10/2006 | US20060178411 Sulfonimide containing compounds and their use in polymer electrolyte membranes for electrochemical cells |
| 08/10/2006 | US20060178408 Phosphodiesterases (PDE); for treating respiratory, nervous system, cardiovascular, inflammatory and allergic diseases, disorders and conditions as well as wounds |
| 08/10/2006 | US20060178403 Antiobesity agent, antidepressants, anxiolytic agents;3-[4-OXO-4H-THIENO[3,2-D]PYRIMIDIN-3-YL]-PYRROLIDINE-1-CARBOXYLIC ACID [1-(PYRROLIDIN-3-YL]-METHYL-AMIDES |
| 08/10/2006 | US20060178401 Aminophenoxyacetamide derivatives and pharmaceutical composition containing thereof |
| 08/10/2006 | US20060178399 Nitrogen-containing heterocyclic derivatives and drugs containing the same as the active ingredient |
| 08/10/2006 | US20060178373 Oxy substituted flavones as antihyperglycemic and antidyslipidemic agents |
| 08/10/2006 | US20060178372 Therapeutic quinoline compounds |
| 08/10/2006 | US20060178366 Compounds for the treatment of inflammatory disorders |
| 08/10/2006 | US20060178365 Optionally oxidized 6-(2-(5-methylthio-2-pyrimidinyloxy)ethoxy)-2-phenylpyrimidin-4-yl-substituted sulfamides |
| 08/10/2006 | DE102005005395A1 New thiazolidinone compounds are polo-like kinase inhibitors, useful for treating e.g. cancer, autoimmune diseases, cardiovascular diseases, infectious diseases, nephrological diseases and viral diseases |